A Novel Mitochondrial DNA Mutation in COX1 Leads to Strokes, Seizures, and Lactic Acidosis

Abstract

Cytochrome c oxidase (COX) is the terminal enzyme of the respiratory chain, with subunits originating both from the mitochondrial and nuclear genome. An eleven-year-old female presented initially with a seizure followed two months later with tonic-clonic seizures, weakness and aphasia. MRI of the cerebral hemispheres showed multiple infarcts. Previous history suggested gross and fine motor control deficits with learning difficulties. A muscle biopsy showed a specific decrease of COX staining in all fibres and pleomorphic mitochondria. Respiratory chain studies confirmed an isolated complex IV defect in muscle, whilst fibroblasts showed an initial COX activity below normal which rapidly came up to the normal range on culture. Sequencing of mtDNA revealed an heteroplasmic m.7023G>A mutation in the COX1 gene, with levels of 96% in muscle, 70% in blood and 50% in the initial skin fibroblast culture dropping to 10% in later passages. The mutation was present in a critical region of the COX1 gene, the V374M change being close to the two histidine residues His376 and His378 co-ordinating with the heme a and a₃, and His367 which co-ordinates a magnesium ion. This case highlights that a MELAS-like syndrome can occur with isolated COX deficiency

cytochrome c oxidase - COX - stroke - seizures - mtDNA mutation

References

• 1 Andrews RM, Kubacka I, Chinnery PF. et al . Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA.  Nat Genet. 1999;  23 147
• 2 Bruno C, Martinuzzi A, Tang Y. et al . A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV.  Am J Hum Genet. 1999;  65 611-620
• 3 Campos Y, Garcia-Redondo A, Fernandez-Moreno MA. et al . Early-onset multisystem mitochondrial disorder caused by a nonsense mutation in the mitochondrial DNA cytochrome C oxidase II gene.  Ann Neurol. 2001;  50 409-413
• 4 Clark KM, Taylor RW, Johnson MA. et al . An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy.  Am J Hum Genet. 1999;  64 1330-1339
• 5 Comi GP, Bordoni A, Salani S. et al . Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease.  Ann Neurol. 1998;  43 110-116
• 6 Corona P, Antozzi C, Carrara F. et al . A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients.  Ann Neurol. 2001;  49 106-110
• 7 Gallardo ME, Moreno-Loshuertos R, Lopez C. et al . m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors.  Hum Mutat. 2006;  27 575-582
• 8 Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).  Biochim Biophys Acta. 1991;  1097 238-240
• 9 Hanna MG, Nelson IP, Rahman S. et al . Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA.  Am J Hum Genet. 1998;  63 29-36
• 10 Horvath R, Scharfe C, Hoeltzenbein M. et al . Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene.  J Med Genet. 2002;  39 812-816
• 11 Ingman M, Gyllensten U. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences.  Nucleic Acids Res. 2006;  34 D749-751
• 12 Jaksch M, Hofmann S, Kleinle S. et al . A systematic mutation screen of 10 nuclear and 25 mitochondrial candidate genes in 21 patients with cytochrome c oxidase (COX) deficiency shows tRNA(Ser)(UCN) mutations in a subgroup with syndromal encephalopathy.  J Med Genet. 1998;  35 895-900
• 13 Karadimas CL, Greenstein P, Sue CM. et al . Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA.  Neurology. 2000;  55 644-649
• 14 Keightley JA, Hoffbuhr KC, Burton MD. et al . A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria.  Nat Genet. 1996;  12 410-416
• 15 Kirby DM, MacFarland R, Ohtake A. et al . Mutations of the mitochondrial ND1 gene as a cause of MELAS.  J Med Genet. 2004;  41 784-789
• 16 Lucioli S, Hoffmeier K, Carrozzo R. et al . Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient.  Neurogenetics. 2006;  7 51-57
• 17 Manfredi G, Schon EA, Moraes CT. et al . A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.  Neuromuscul Disord. 1995;  5 391-398
• 18 Merante F, Tein I, Benson L. et al . Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene.  Am J Hum Genet. 1994;  55 437-446
• 19 Merante F, Myint T, Tein I. et al . An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy.  Hum Mutat. 1996;  8 216-222
• 20 Pecina P, Houstkova H, Hansikova H. et al . Genetic defects of cytochrome c oxidase assembly.  Physiol Res. 2004;  53 ((Suppl 1)) S213-S223
• 21 Polyak K, Li Y, Zhu H. et al . Somatic mutations of the mitochondrial genome in human colorectal tumours.  Nat Genet. 1998;  20 291-293
• 22 Rahman S, Taanman JW, Cooper JM. et al . A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy.  Am J Hum Genet. 1999;  65 1030-1039
• 23 Rasband WS, Image J. In: U. S. National Institutes of Health, Bethesda, Maryland, USA. 1997–2007
• 24 Robinson BH, Glerum DM, Chow W. et al . The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia.  Pediatr Res. 1990;  28 549-555
• 25 Ruiz-Pesini E, Lott MT, Procaccio V. et al . An enhanced MITOMAP with a global mtDNA mutational phylogeny.  Nucleic Acids Res. 2007;  35 D823-D828
• 26 Santorelli FM, Tanji K, Kulikova R. et al . Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS.  Biochemical and biophysical research communications. 1997;  238 326-328
• 27 Seneca S, Abramowicz M, Lissens W. et al . A mitochondrial DNA microdeletion in a newborn girl with transient lactic acidosis.  J Inherit Metab Dis. 1996;  19 115-118
• 28 Taanman JW. Human cytochrome c oxidase: structure, function, and deficiency.  J Bioenerg Biomembr. 1997;  29 151-163
• 29 Taylor RW, Taylor GA, Durham SE. et al . The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations.  Nucleic Acids Res. 2001;  29 E74
• 30 Uusimaa J, Finnila S, Vainionpaa L. et al . A mutation in mitochondrial DNA-encoded cytochrome c oxidase II gene in a child with Alpers-Huttenlocher-like disease.  Pediatrics. 2003;  111 e262-268
• 31 Varlamov DA, Kudin AP, Vielhaber S. et al . Metabolic consequences of a novel missense mutation of the mtDNA CO I gene.  Hum Mol Genet. 2002;  11 1797-1805

Correspondence